这些大品种要大卖了!片仔癀、蒲地蓝…

2018-01-11 整理:Chris 赛柏蓝

昨日(1月10日),吉林省人社厅发布《关于印发吉林省基本医疗保险、工伤保险和生育保险药品目录(2017年版)的通知》。

昨日(1月10日),吉林省人社厅发布《关于印发吉林省基本医疗保险、工伤保险和生育保险药品目录(2017年版)的通知》。

严格监管医保支付

通知要要求,严格药品费用支付管理,加大监督检查力度。

医师开具西药处方须符合西医疾病诊治原则,开具中药处方须遵循中医辨证施治原则和理法方药,对于每一最小分类下的同类药品原则上不宜叠加使用。

对按西医诊断开具中成药、按中医诊断开具西药等不合理用药、重复用药和药物滥用等,要明确相应的处罚措施并纳入定点协议管理

要采取措施鼓励医师按照先甲类后乙类、先口服制剂后注射制剂、先常释剂型后缓(控)释剂型等原则选择药品,鼓励药师在调配药品时首先选择相同品种剂型中副作用较小、价格低廉的药品。

众多大品种进增补目录

根据吉林省2017版的医保目录,与国家版相比,做了适当的调整。

吉林的医保乙类目录共增补了299个品种,其中西药118个,中药181个(含民族药)。1月1日开始执行,1个月过渡期。

增补的西药中,包括单唾液酸四己糖神经节苷脂注射剂,脑蛋白水解物注射剂、小牛血去蛋白提取物注射剂等。

增补的中药中,包括片仔癀、蒲地蓝消炎口服液、玉屏风口服液等。

这些都是市场畅销的大品种,虽未能进入国家医保目录,但是能顺利增补进吉林省目录,确实可喜可贺。

附:吉林省增补医保药品目录

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2052710, encodeId=687a2052e10a8, content=<a href='/topic/show?id=e54c4365204' target=_blank style='color:#2F92EE;'>#大品种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43652, encryptionId=e54c4365204, topicName=大品种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Sun Feb 25 05:45:00 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043120, encodeId=932320431206b, content=<a href='/topic/show?id=44356e463c6' target=_blank style='color:#2F92EE;'>#片仔癀#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67463, encryptionId=44356e463c6, topicName=片仔癀)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d784426, createdName=isabellayj, createdTime=Sat May 05 20:45:00 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424955, encodeId=48e51424955b3, content=<a href='/topic/show?id=d0cb88331c8' target=_blank style='color:#2F92EE;'>#蒲地蓝#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88331, encryptionId=d0cb88331c8, topicName=蒲地蓝)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f86e3938020, createdName=yanghan, createdTime=Sat Jan 13 00:45:00 CST 2018, time=2018-01-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2052710, encodeId=687a2052e10a8, content=<a href='/topic/show?id=e54c4365204' target=_blank style='color:#2F92EE;'>#大品种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43652, encryptionId=e54c4365204, topicName=大品种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Sun Feb 25 05:45:00 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043120, encodeId=932320431206b, content=<a href='/topic/show?id=44356e463c6' target=_blank style='color:#2F92EE;'>#片仔癀#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67463, encryptionId=44356e463c6, topicName=片仔癀)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d784426, createdName=isabellayj, createdTime=Sat May 05 20:45:00 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424955, encodeId=48e51424955b3, content=<a href='/topic/show?id=d0cb88331c8' target=_blank style='color:#2F92EE;'>#蒲地蓝#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88331, encryptionId=d0cb88331c8, topicName=蒲地蓝)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f86e3938020, createdName=yanghan, createdTime=Sat Jan 13 00:45:00 CST 2018, time=2018-01-13, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2052710, encodeId=687a2052e10a8, content=<a href='/topic/show?id=e54c4365204' target=_blank style='color:#2F92EE;'>#大品种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43652, encryptionId=e54c4365204, topicName=大品种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b30d401, createdName=huangshifeng, createdTime=Sun Feb 25 05:45:00 CST 2018, time=2018-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2043120, encodeId=932320431206b, content=<a href='/topic/show?id=44356e463c6' target=_blank style='color:#2F92EE;'>#片仔癀#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=67463, encryptionId=44356e463c6, topicName=片仔癀)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d784426, createdName=isabellayj, createdTime=Sat May 05 20:45:00 CST 2018, time=2018-05-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1424955, encodeId=48e51424955b3, content=<a href='/topic/show?id=d0cb88331c8' target=_blank style='color:#2F92EE;'>#蒲地蓝#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=88331, encryptionId=d0cb88331c8, topicName=蒲地蓝)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f86e3938020, createdName=yanghan, createdTime=Sat Jan 13 00:45:00 CST 2018, time=2018-01-13, status=1, ipAttribution=)]
    2018-01-13 yanghan

相关资讯

东北三省一区“两票制”互认 药品流通企业将大洗牌

8月24日,吉林省医药采购中心公布《关于公示“东北三省一区”公立医疗机构药品采购“两票制”界定结果的通知》。